[HTML] springer.comFull View

[HTML][HTML] Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

C Chen, H Wang, X Geng, D Zhang, Z Zhu… - Cancer cell …, 2021 - Springer
Background Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …
被引用次数：23 相关文章

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway.

C Chen, H Wang, X Geng, D Zhang, Z Zhu… - Cancer Cell …, 2021 - europepmc.org
Background Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway.

C Chen, H Wang, X Geng, D Zhang, Z Zhu… - Cancer Cell …, 2021 - go.gale.com
Background Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …
[HTML] nih.gov

[HTML][HTML] Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

C Chen, H Wang, X Geng, D Zhang, Z Zhu… - Cancer Cell …, 2021 - ncbi.nlm.nih.gov
Background Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

C Chen, H Wang, X Geng, D Zhang… - Cancer Cell …, 2021 - search.proquest.com
Background Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

C Chen, H Wang, X Geng, D Zhang… - Cancer cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway.

C Chen, H Wang, X Geng, D Zhang… - Cancer Cell …, 2021 - search.ebscohost.com
Background: Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …
[HTML] biomedcentral.com

[HTML][HTML] Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

C Chen, H Wang, X Geng, D Zhang… - Cancer Cell …, 2021 - cancerci.biomedcentral.com
Encouraged by the goal of developing an effective treatment strategy for prostate cancer,
this study explored the mechanism involved in metformin-mediated inhibition of AR-negative …
[PDF] archive.org

[PDF][PDF] Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

C Chen, H Wang, X Geng, D Zhang, Z Zhu, G Zhang… - 2021 - scholar.archive.org
Background: Encouraged by the goal of developing an effective treatment strategy for
prostate cancer, this study explored the mechanism involved in metformin-mediated …
[HTML] biomedcentral.com

[HTML][HTML] Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

C Chen, H Wang, X Geng, D Zhang… - Cancer Cell …, 2021 - cancerci.biomedcentral.com
Encouraged by the goal of developing an effective treatment strategy for prostate cancer,
this study explored the mechanism involved in metformin-mediated inhibition of AR-negative …